Depletion of Resistance Vessel Polyamines Attenuates Angiotensin II Induced Blood Pressure Rise in Rats

References

• Janne J., Poso H., Raina A. Polyamines in rapid growth and cancer. Biochim Biophys Acta. 1978; 473: 241–293
   PubMed Web of Science ®Google Scholar
• Tabor C. W, Tabor H. Polyamines. Annu Rev Biochem. 1984; 53: 749–790
   PubMed Web of Science ®Google Scholar
• Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation 1981; 19: 1–20
   PubMed Web of Science ®Google Scholar
• Russel D. H, Durie B. G. Polyamines as biochemical markers of normal and malignant growth In Progress in Cancer Research and Therapy. New York: Raven Press. 1978; 8: 1–78
   Google Scholar
• Seiler N., Heby O. Regulation of cellular polyamines in mammals. Acta Biochim Biophys Hung. 1988; 23: 1–35
   PubMedGoogle Scholar
• Metcalf B. W, Bey P., Danzin C., Jung M J, Casara P., Vevert J. P. Catalytic irreversible inhibition of mammalian ornithine decarboxyalse by substrate and product analogues. J Am Chem Soc. 1978; 100: 2551–2553
   Web of Science ®Google Scholar
• Janne J., Holtta E., Kallio A., Kapyaho K. Role of polyamines and their antimetabolites in clinical medicine. Spec Top Endocrinol Metab. 1983; 5: 227–293
   PubMedGoogle Scholar
• Danzin C., Mamont P. S. Polyamine inhibition in vivo and in organ growth and repair. Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies, P P McCann, A E Pegg, A Sjoerdsma. Orlando Academic Press. 1987; 141–164
   Google Scholar
• Sunkara P. S, Baylin S. B, Luk G. D. Inhibitors of polyamine biosynthesis. Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies, P. P McCann, A. E Pegg, A. Sjoerdsma. Orlando Academic Press. 1987; 121–140
   Google Scholar
• Pegg A. E, McCann P. P. Polyamine metabolism and function. Am J Physiol 1982; 243: C212–C221
   PubMed Web of Science ®Google Scholar
• Folkow B. Structural factor in primary and secondary hypertension. Hypertension 1990; 16: 89–101
   PubMed Web of Science ®Google Scholar
• Mulvany M. J. The fourth Sir George Pickering Memorial Lecture The structure of the resistance vasculature in essential hypertension. J Hypertens 1987; 5: 129–36
   PubMed Web of Science ®Google Scholar
• Korner P. I, Bobik A., Angus J. A, Adams M. A, Friberg P. Resistance control in hypertension. J Hypertens 1989; 7: S125–34
   Web of Science ®Google Scholar
• Dahlof B. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review. Drugs 1988; 35: S6–26.
   Google Scholar
• Korner P. I, Angus J. A, Bobik A., Jennings G. L. Amplifier function of resistance vessels and the left ventricle in hypertension. J Hypertens 1991; 9: S313–40
   Google Scholar
• Folkow B. The fourth Volhard lecture Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med 1978; 4: 3S–22S
   Google Scholar
• Folkow B. “Structural factor” in primary and secondary hypertension. Hypertension 1990; 16: 89–101
   PubMed Web of Science ®Google Scholar
• Lever A. F. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels?. J Hypertens 1986; 4: 515–524
   PubMed Web of Science ®Google Scholar
• Ibrahim J., Schachter M., Hughes A. D, Sever P. S. Role of polyamines in angiotensin II induced hypertension. Cardiovas Res 1995; 29: 50–56
   PubMed Web of Science ®Google Scholar
• Lee R. M, Forrest J. B, Garfield R. E, Daniel E. E. Comparison of blood vessel wall dimensions in normotensive hypertensive rats by histometric and morphometric methods. Blood Vessels 1983; 20: 245–254
   PubMedGoogle Scholar
• Zhong Y, Zhang R. HPLC determination of polyamines in the femtomole range. Biomed Chromatogr 1987; 2: 173–176
   PubMedGoogle Scholar
• Sabri M. I, Soiefer A. I, Kisby G. E, Spencer P. S. Determination of polyamines by precolumn derivatization with 9-fluorenylmethyl chloroformate and reverse-phase high-performance liquid chromatography. J Neurosci Methods 1989; 29: 27–31
   PubMed Web of Science ®Google Scholar
• Janne J., Alnonen-Honigsto L, Seppaen P., Holtta E. Cellular compensatory mechanisms during chemically induced polyamine deprivation. Advances in Polyamine Research, C. M Caldarera. Raven Press, New York 1981; 3: 85–95
   Google Scholar
• Soltis E. E, Newman P. S, Olson J. W. Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension. Hypertension 1991; 18: 85–92
   PubMed Web of Science ®Google Scholar
• Mathy C. Polyamines and cardiovascular hypertrophy in experimental hypertension. Arch Mal Coeur Vaiss 1987; 80: 777–782
   PubMedGoogle Scholar
• Christensen H. R.L, Nielsen H., Christensen K. L, Baandrup U., Jespersen L T, Mulvany M. J. Long-term effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure?. J Hypertens 1988; 6: S27–31
   Web of Science ®Google Scholar
• Griffin S. A, Brown W. C, MacPherson F., McGrath J. C, Wilson V. G, Korsgaard N., Mulvany M. J, Lever A. F. Angiotensin II causes vascular hypertrophy in part by a non- pressor mechanism. Hypertension 1991; 17: 626–635
   PubMed Web of Science ®Google Scholar
• Thompson K. E, Friberg P., Adams M. A. Vasodilators inhibit acute alpha 1-adrenergic receptor-induced trophic responses in the vasculature. Hypertension 1992; 20: 809–815
   PubMed Web of Science ®Google Scholar
• Van Kleef E M, Smits J. F, De Mey J G, Cleutjens J. P, Lombardi D. M, Schwartz S. M, Daemen M. J. Alpha 1-adrenoreceptor blockade reduces the angiotensin II- induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res 1992; 70: 1122–1127
   PubMed Web of Science ®Google Scholar
• Duff J. L, Marrero M. B, Paxton W. P, Schieffer B, Bernstein K E, Berk B. C. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovas Res 1995; 30: 51–517
   Google Scholar
• Marrero M. B, Schieffer B., Paxton W. P, Duff J. L, Berk B. C, Bernstein K. E. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovas Res 1995; 30: 530–536
   PubMed Web of Science ®Google Scholar